Autopsy report · NCT00210119
Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response
Cause of deathNo reason given
Life of this trial
- Registered 10 months before it started.
- Ran for about 2 years 8 months before it stopped.
- 19 participants enrolled.
- Results were posted on the registry 12 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Institut Bergonié
- Sponsor type
- University, hospital or other
- Conditions
- Myeloid Leukemia, Chronic
- Interventions
- Glivec
- Participants
- 19
- Sites
- 7
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.